Study of interaction between PRAS40 and 14-3-3 proteins by using yeast two-hybrid system

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 23, Issue 4, 2007, Pages 652-656

  Liu, Kang Wu ^a   Huang, Bei ^a   Tan, Yang ^a   Wu, Dong Ming ^a  

^a ANHUI UNIVERSITY   (China)

Author keywords

14 3 3; Gateway cloning technology; PRAS40; Yeast two hybrid

Indexed keywords

AKT1S1 PROTEIN, HUMAN; ISOPROTEIN; PHOSPHOPROTEIN; PROTEIN 14 3 3;

ARTICLE; GENETICS; HUMAN; METABOLISM; PROTEIN BINDING; TWO HYBRID SYSTEM;

14-3-3 PROTEINS; HUMANS; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN ISOFORMS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 67651022168     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Fu H, Subramanian RR, Masters SC. 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol. 2000, 40: 617-647.
2. Kristina KS, Park GY, Bea SK, et al. Identification of a proline-rich akt substrate as a 14-3-3 binding partner. J B C, 2003, 12: 10189-10194.
3. Saito A, Narasimhan P, Hayashi T, et al. Neuroprotective role of a proline-rich akt substrate in apoptotic neuronal cell death after stroke: relationships with nerve growth factor. Journal of Neuroscience. 2004, 24(7): 1584-1593.
4. Huang B, Porter G. Expression of praline-rich Akt substrate PRAS40 in cell survival pathway and carcinogenesis. Acta Pharmacologica Sinica, 2005, 26(10): 1253-1258.
5. Haar EV, Lee S, Brandhakavi S, et al. Insulin signaling to mTOR mediated by the Akt/PKB substrate PRAS40. Nature Cell Biology Letters, 2007, 9(3): 316-323.
6. Kjarland E, Keen TJ, Kleppe R. Does isoform diversity explain functional differences in the 14-3-3 protein family? Review. Current Pharmaceutical Biotechnology, 2006, 7(3): 217-223.
7. Yaffe MB. How do 14-3-3 proteins work? - Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Letters, 2002, 513: 53-57.
8. Liu B, Bienkowska J, Petosa C, et al. Crystal structure of the ζ isoform of the 14-3-3 protein. Nature, 1995, 376: 191-194.
9. Aitken A, Gamblin SJ. Structure of a 14-3-3 protein and implications for coordination of multiple signaling pathways. Nature, 1995, 376: 188-191.
10. Benzinger A, Popowicz GM, Joy JK, et al. The crystal structure of the non-liganded 14-3-3σ protein: insights into determinants of isoform specific ligand binding and dimerization. Cell Research, 2005, 15(4): 219-227.
11. Yaffe MB, Rittinger K, Volinia S, et al. The structural basis for 14-3-3: phosphopeptide binding specificity. Cell, 1997, 91: 961-971.
12. Zhang LX, Chen J, Fu H. Suppression of apoptosis signal-regulation Kinase1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci USA, 1999, 96(7): 8511-8515.
13. Subramanian RR, Masters SC, Zhang H, et al. Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. Exp Cell Res, 2001, 271(1): 142-151.
14. Hui L, Ji ZN, Cai WQ, et al. Identification of DAT1/LIM2-interacting proteins by yeast two-hybrid screening. Acta Academiae Medicinae Militaris Tertiae, 2005, 27(5): 410-414.